Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 23, 2021

SELL
$19.92 - $31.6 $39,840 - $63,200
-2,000 Closed
0 $0
Q4 2020

Jan 29, 2021

BUY
$12.16 - $19.77 $24,320 - $39,540
2,000 New
2,000 $40,000
Q3 2020

Oct 20, 2020

SELL
$11.25 - $14.75 $22,500 - $29,500
-2,000 Closed
0 $0
Q1 2020

Apr 22, 2020

BUY
$9.78 - $29.53 $19,560 - $59,060
2,000 New
2,000 $29,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.31B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Joseph P. Lucia & Associates, LLC Portfolio

Follow Joseph P. Lucia & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Joseph P. Lucia & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Joseph P. Lucia & Associates, LLC with notifications on news.